UBS Group
ABEOW

UBS Group’s Abeona Therapeutics Inc Warrant ABEOW Stock Holding History

UBS Group’s Portfolio ABEOW Stock Details ABEOW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-538
Closed -$2K – 8472
2018
Q4 		$2K Sell
538
-295
-35% -$1.35K ﹤0.01% 7845
2018
Q3 		$7K Sell
833
-255
-23% -$2.37K ﹤0.01% 7376
2018
Q2 		$11K Buy
1,088
+843
+344% +$10.9K ﹤0.01% 7101
2018
Q1 		$2K Buy
+245
New +$2.44K ﹤0.01% 7587
2017
Q4 		– Sell
-100
Closed -$1K – 8262
2017
Q3 		$1K Buy
+100
New +$664 ﹤0.01% 7630
2017
Q1 		– Sell
-800
Closed -$2K – 8188
2016
Q4 		$2K Buy
+800
New +$2.69K ﹤0.01% 7555
2016
Q2 		– Sell
-1,310
Closed -$1K – 8117
2016
Q1 		$1K Buy
1,310
+525
+67% +$417 ﹤0.01% 7501
2015
Q4 		$1K Buy
785
+23
+3% +$35 ﹤0.01% 8214
2015
Q3 		$1K Buy
+762
New +$1.49K ﹤0.01% 8270

Other funds holding ABEOW

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

UBS Group's ABEOW Position: Q1 2019 in Review

UBS Group sold out of Abeona Therapeutics Inc Warrant (ABEOW) in Q1 2019, closing a stake of 538 shares — an estimated $2K sold.

UBS Group first reported a position in ABEOW in Q3 2015 and held it in 9 quarters. The position peaked at $11K in Q2 2018. 4 funds tracked by Wall St. Rank hold ABEOW as of Q1 2019.

  • UBS Group reported no remaining Abeona Therapeutics Inc Warrant position as of Q1 2019 after selling out during the quarter.
  • UBS Group sold 538 Abeona Therapeutics Inc Warrant shares in Q1 2019, an estimated $2K.
  • UBS Group first reported a position in Abeona Therapeutics Inc Warrant in Q3 2015 and held it in 9 quarters.
  • UBS Group's Abeona Therapeutics Inc Warrant position peaked at $11K in Q2 2018.
  • 4 funds tracked by Wall St. Rank held Abeona Therapeutics Inc Warrant as of Q1 2019.

Based on UBS Group's 13F filing for Q1 2019, filed 14 May 2019.